Vital Sensory Kit For Use With Telemedicine In Developing Countries

In many developing countries, a large percentage of the population lacks access to adequate healthcare. This is especially true in India where close to 70% of the population lives in rural areas and has little to no access to hospitals or clinics. People living in rural India often times cannot afford to pay to see a doctor should they need to make the journey to a hospital. Telemedicine, a breakthrough in the past couple decades, has broken down the barrier between the patient and the physician. It has slowly been implemented in India to make doctors more available to patients through the use of video conferences and other forms of communication. A compact and affordable kit has been developed that will be used to take a patient’s blood pressure, heart rate, blood glucose concentration and oxygen saturation. Our most novel contribution is the non-invasive glucose sensor that will use a near-infrared LED and photodiode in the patient’s earlobe. Currently millions of diabetics do this by pricking their finger. By wirelessly sending data results from the vital sign kit, the first essential part of a treatment can be carried out via wireless communication, saving the doctor and patient time and money

Telemonitoring in the Covid-19 era: The tuscany region experience

Covid-19 has brought many difficulties in the management of infected and high-risk patients. Telemedicine platforms can really help in this situation, since they allow remotely monitoring Covid-19 patients, reducing the risk for the doctors, without decreasing the efficiency of the therapies and while alleviating patients’ mental issues. In this paper, we present the entire architecture and the experience of using the Tel.Te.Covid19 telemedicine platform. Projected for the treatment of chronic diseases, it has been technologically updated for the management of Covid-19 patients with the support of a group of doctors in the territory when the pandemic arrived, introducing new sensors and functionalities (e.g., the familiar use and video calls). In Tuscany (Central Italy), during the first wave of outbreak, a model for enrolling patients was created and tested. Because of the positive results, the latter has been then adopted in the second current wave. The Tel.Te.Covid19 platform has been used by 40 among general practitioners and doctors of continuity care and about 180 symptomatic patients since March 2020. Both patients and doctors have good opinion of the platform, and no hospitalisations or deaths occurred for the monitored patients, reducing also the impact on the National Healthcare System

M-health review: joining up healthcare in a wireless world

In recent years, there has been a huge increase in the use of information and communication technologies (ICT) to deliver health and social care. This trend is bound to continue as providers (whether public or private) strive to deliver better care to more people under conditions of severe budgetary constraint

Arogyasree: An Enhanced Grid-Based Approach to Mobile Telemedicine

A typical telemedicine system involves a small set of hospitals providing remote healthcare services to a small section of the society using dedicated nodal centers. However, in developing nations like India where majority live in rural areas that lack specialist care, we envision the need for much larger Internet-based telemedicine systems that would enable a large pool of doctors and hospitals to collectively provide healthcare services to entire populations. We propose a scalable, Internet-based P2P architecture for telemedicine integrating multiple hospitals, mobile medical specialists, and rural mobile units. This system, based on the store and forward model, features a distributed context-aware scheduler for providing timely and location-aware telemedicine services. Other features like zone-based overlay structure and persistent object space abstraction make the system efficient and easy to use. Lastly, the system uses the existing internet infrastructure and supports mobility at doctor and patient ends

The Role of Telehealth in Disaster Management: Lessons for the Philippines

According to the WorldRiskIndex 2016, the Philippines is the third country most at risk of disasters in the world. Typhoon Haiyan, the strongest on local record, caused widespread destruction to life and property. Current disaster management strategies in the country do not include telehealth as a formal tool in disaster mitigation, response, or recovery. This study reviewed research incorporating telehealth in disaster management from multiple low and lower middle income countries like the Philippines to address this gap by identifying lessons the country might be able to adopt. Studies show that most initiatives centre on evaluating telehealth’s effectiveness during the response phase. Unsurprisingly, mobile technology and satellite communications predominated, and most projects were launched using donor funding. Use of telehealth in disaster management in the Philippines could begin by recognising and including telehealth in formal government protocols. The government could leverage the National Telehealth Service Program of the University of the Philippines National Telehealth Center. Documentation and systematic research on telehealth’s expected positive contributions to disaster preparedness and response should also be initiated

CASCADE baseline review of current partner technology enabled care service (TECS) initiatives and proposal for a collaborative evaluation strategy

This report covers D 3.3.1 and D3.3.2 of the CASCADE project providing a preliminary summary of existing telemedicine/telehealth technologies reported in the literature alongside an analysis of existing usage reported by partner sites PP2, 3, 5, 6 and 8. Partners were asked to provide information that addressed a series of questions summarised below. 1. What technology you are currently using and why? 2. When was the technology introduced and how is it being used with what kinds of populations of residents/patients/clients/staff including the reach (numbers)? 3. How much has this technology cost to be introduced (set up costs) and how much does it cost to run (running costs)? 4. What evidence has your organisation collected to date to show what beneficial impacts it is having and why? 5. What metrics does your organisation use to demonstrate the link between the technology and improvements in quality of life indicators for your client groups/staff groups (this may be Prezo/ Belrai/ InterRai data as well as staff wellbeing survey data) and feedback from relatives and families in satisfaction questionnaires? 6. What intentions, if any, do you have to expand or introduce new telemedicine/ e-health technologies? 7. What baseline financial figures do you have to support the introduction of the technology that you can share

Recent Advances in Health Biotechnology During Pandemic

The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which emerged in 2019, cut the epoch that will make profound fluctuates in the history of the world in social, economic, and scientific fields. Urgent needs in public health have brought with them innovative approaches, including diagnosis, prevention, and treatment. To exceed the coronavirus disease 2019 (COVID-19) pandemic, various scientific authorities in the world have procreated advances in real time polymerase chain reaction (RT-PCR) based diagnostic tests, rapid diagnostic kits, the development of vaccines for immunization, and the purposing pharmaceuticals for treatment. Diagnosis, treatment, and immunization approaches put for- ward by scientific communities are cross-fed from the accrued knowledge of multidisciplinary sciences in health biotechnology. So much so that the pandemic, urgently prioritized in the world, is not only viral infections but also has been the pulsion in the development of novel approaches in many fields such as diagnosis, treatment, translational medicine, virology, mi- crobiology, immunology, functional nano- and bio-materials, bioinformatics, molecular biol- ogy, genetics, tissue engineering, biomedical devices, and artificial intelligence technologies. In this review, the effects of the COVID-19 pandemic on the development of various scientific areas of health biotechnology are discussed